A kind of externally-applied medicinal composition treating cutaneous fungal infection

A kind of externally-applied medicinal composition treating cutaneous fungal infection

  • CN 102,727,494 B
  • Filed: 10/31/2009
  • Issued: 08/17/2016
  • Est. Priority Date: 10/31/2009
  • Status: Active Grant
First Claim
Patent Images

1. the externally-applied medicinal composition treating cutaneous fungal infection, it is characterised in that it contains following active component:

  • (1) cyclooxygenase inhibitors of squalene;

    With(2) H1 receptor antagonist,Described cyclooxygenase inhibitors of squalene is terbinafine or its officinal salt, and described H1 receptor antagonist isCetirizine, levocetirizine, loratadine, Desloratadine or their officinal salt;

    Described squalene epoxidaseInhibitor is 10;

    1~

    0.5;

    1 with the weight ratio of H1 receptor antagonist.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×